No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor / blood
-
Cost-Benefit Analysis
-
Female
-
Fluorine Radioisotopes
-
Fluorodeoxyglucose F18
-
Humans
-
Lymphatic Metastasis / diagnostic imaging*
-
Magnetic Resonance Imaging
-
Neoadjuvant Therapy
-
Neoplasm Staging / methods
-
Positron-Emission Tomography* / economics
-
Radiopharmaceuticals
-
Salvage Therapy
-
Time Factors
-
Tomography, X-Ray Computed
-
Uterine Cervical Neoplasms / blood
-
Uterine Cervical Neoplasms / diagnostic imaging*
-
Uterine Cervical Neoplasms / drug therapy
-
Uterine Cervical Neoplasms / pathology
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Fluorine Radioisotopes
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18